Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trialXuan, Li ; Wang, Yu ; Huang, Fen ; Fan, Zhiping ; Xu, Yajing ; Sun, Jing ; Xu, Na ; Deng, Lan ; Li, Xudong ; Liang, Xinquan ; Luo, Xiaodan ; Shi, Pengcheng ; Liu, Hui ; Wang, Zhixiang ; Jiang, Ling ; Yu, Chunzi ; Zhou, Xuan ; Lin, Ren ; Chen, Yan ; Tu, Sanfang ; Huang, Xiaojun ; Liu, QifaThe lancet oncology, 2020-09, Vol.21 (9), p.1201-1212 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control studyGillis, Nancy K, PharmD ; Ball, Markus, PhD ; Zhang, Qing, MD ; Ma, Zhenjun, PhD ; Zhao, YuLong, PhD ; Yoder, Sean J, MS ; Balasis, Maria E, BS ; Mesa, Tania E, BS ; Sallman, David A, MD ; Lancet, Jeffrey E, Prof ; Komrokji, Rami S, Prof ; List, Alan F, Prof ; McLeod, Howard L, Prof ; Alsina, Melissa, Prof ; Baz, Rachid, MD ; Shain, Kenneth H, MD ; Rollison, Dana E, PhD ; Padron, Eric, DrThe lancet oncology, 2017-01, Vol.18 (1), p.112-121 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia modelWang, Rong ; Feng, Wenli ; Wang, Hao ; Wang, Lina ; Yang, Xiao ; Yang, Feifei ; Zhang, Yingchi ; Liu, Xiaoli ; Zhang, Dongyue ; Ren, Qian ; Feng, Xiaoming ; Zheng, GuoguangCancer letters, 2020-01, Vol.469, p.151-161 [Periódico revisado por pares]Ireland: Elsevier B.VTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitorsLargeaud, Laetitia ; Bérard, Emilie ; Bertoli, Sarah ; Dufrechou, Stéphanie ; Prade, Naïs ; Gadaud, Noémie ; Tavitian, Suzanne ; Bories, Pierre ; Luquet, Isabelle ; Sarry, Audrey ; De Mas, Véronique ; Huguet, Françoise ; Delabesse, Eric ; Récher, ChristianLeukemia research, 2019-06, Vol.81, p.82-87 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 studyPerl, Alexander E, MD ; Altman, Jessica K, MD ; Cortes, Jorge, MD ; Smith, Catherine, MD ; Litzow, Mark, MD ; Baer, Maria R, MD ; Claxton, David, Prof ; Erba, Harry P, Prof ; Gill, Stan, PhD ; Goldberg, Stuart, MD ; Jurcic, Joseph G, Prof ; Larson, Richard A, Prof ; Liu, Chaofeng, PhD ; Ritchie, Ellen, MD ; Schiller, Gary, MD ; Spira, Alexander I, MD ; Strickland, Stephen A, MD ; Tibes, Raoul, MD ; Ustun, Celalettin, MD ; Wang, Eunice S, Prof ; Stuart, Robert, Prof ; Röllig, Christoph, MD ; Neubauer, Andreas, Prof ; Martinelli, Giovanni, Prof ; Bahceci, Erkut, MD ; Levis, Mark, DrThe lancet oncology, 2017-08, Vol.18 (8), p.1061-1075 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trialDiNardo, Courtney D ; Schuh, Andre C ; Stein, Eytan M ; Montesinos, Pau ; Wei, Andrew H ; de Botton, Stéphane ; Zeidan, Amer M ; Fathi, Amir T ; Kantarjian, Hagop M ; Bennett, John M ; Frattini, Mark G ; Martin-Regueira, Patricia ; Lersch, Frederik ; Gong, Jing ; Hasan, Maroof ; Vyas, Paresh ; Döhner, HartmutThe lancet oncology, 2021-11, Vol.22 (11), p.1597-1608 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialRubnitz, Jeffrey E, Prof ; Inaba, Hiroto, MD ; Dahl, Gary, Prof ; Ribeiro, Raul C, Prof ; Bowman, W Paul, Prof ; Taub, Jeffrey, MD ; Pounds, Stanley, PhD ; Razzouk, Bassem I, MD ; Lacayo, Norman J, MD ; Cao, Xueyuan, PhD ; Meshinchi, Soheil, MD ; Degar, Barbara, MD ; Airewele, Gladstone, MD ; Raimondi, Susana C, Prof ; Onciu, Mihaela, MD ; Coustan-Smith, Elaine, MS ; Downing, James R, Prof ; Leung, Wing, Prof ; Pui, Ching-Hon, Prof ; Campana, Dario, ProfThe lancet oncology, 2010-06, Vol.11 (6), p.543-552 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control studyTakahashi, Koichi, MD ; Wang, Feng, PhD ; Kantarjian, Hagop, Prof ; Doss, Denaha, MS ; Khanna, Kanhav, MS ; Thompson, Erika, MS ; Zhao, Li, PhD ; Patel, Keyur, MD ; Neelapu, Sattva, MD ; Gumbs, Curtis, BS ; Bueso-Ramos, Carlos, Prof ; DiNardo, Courtney D, MD ; Colla, Simona, PhD ; Ravandi, Farhad, Prof ; Zhang, Jianhua, PhD ; Huang, Xuelin, PhD ; Wu, Xifeng, Prof ; Samaniego, Felipe, MD ; Garcia-Manero, Guillermo, Prof ; Futreal, P Andrew, ProfThe lancet oncology, 2017, Vol.18 (1), p.100-111 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trialsHills, Robert K, DPhil ; Castaigne, Sylvie, Prof ; Appelbaum, Frederick R, Prof ; Delaunay, Jacques, MD ; Petersdorf, Stephen, MD ; Othus, Megan, PhD ; Estey, Elihu H, Prof ; Dombret, Hervé, Prof ; Chevret, Sylvie, PhD ; Ifrah, Norbert, Prof ; Cahn, Jean-Yves, Prof ; Récher, Christian, Prof ; Chilton, Lucy, PhD ; Moorman, Anthony V, Prof ; Burnett, Alan K, ProfThe lancet oncology, 2014-08, Vol.15 (9), p.986-996 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantationMetzelder, S.K. ; Schroeder, T. ; Lübbert, M. ; Ditschkowski, M. ; Götze, K. ; Scholl, S. ; Meyer, R.G. ; Dreger, P. ; Basara, N. ; Fey, M.F. ; Salih, H.R. ; Finck, A. ; Pabst, T. ; Giagounidis, A. ; Kobbe, G. ; Wollmer, E. ; Finke, J. ; Neubauer, A. ; Burchert, A.European journal of cancer (1990), 2017-11, Vol.86, p.233-239 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |